Cargando…

Elevated fecal peptidase D at onset of colitis in Galphai2(-/-) mice, a mouse model of IBD

BACKGROUND: The identification of novel fecal biomarkers in inflammatory bowel disease (IBD) is hampered by the complexity of the human fecal proteome. On the other hand, in experimental mouse models there is probably less variation. We investigated the fecal protein content in mice to identify poss...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bergemalm, Daniel, Kruse, Robert, Sapnara, Maria, Halfvarson, Jonas, Hörnquist, Elisabeth Hultgren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360340/ https://www.ncbi.nlm.nih.gov/pubmed/28323866 http://dx.doi.org/10.1371/journal.pone.0174275

Ejemplares similares

A Quantitative Study of the Mechanisms behind Thymic Atrophy in Gαi2-Deficient Mice during Colitis Development
por: Elgbratt, Kristina, et al.
Publicado: (2012)

Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis
por: Günaltay, Sezin, et al.
Publicado: (2017)

Diagnosis and management of microscopic colitis: current perspectives
por: Bohr, Johan, et al.
Publicado: (2014)

CD4(+)FoxP3(+) Regulatory T Cells from Gαi2(−/−) Mice Are Functionally Active In Vitro, but Do Not Prevent Colitis
por: Götlind, Yu-Yuan C., et al.
Publicado: (2011)

Enhanced Levels of Chemokines and Their Receptors in the Colon of Microscopic Colitis Patients Indicate Mixed Immune Cell Recruitment
por: Günaltay, Sezin, et al.
Publicado: (2015)

Prognostic Biosignatures at Ileocecal Resection: Hope or Reality?
por: Salomon, Benita, et al.
Publicado: (2021)

Patients With Microscopic Colitis Have Altered Levels of Inhibitory and Stimulatory Biomarkers in Colon Biopsies and Sera Compared to Non-inflamed Controls
por: Lushnikova, Alexandra, et al.
Publicado: (2021)

Reduced T Cell Receptor Excision Circle Levels in the Colonic Mucosa of Microscopic Colitis Patients Indicate Local Proliferation rather than Homing of Peripheral Lymphocytes to the Inflamed Mucosa
por: Kumawat, Ashok Kumar, et al.
Publicado: (2013)

An In Vitro Model to Evaluate the Impact of the Soluble Factors from the Colonic Mucosa of Collagenous Colitis Patients on T Cells: Enhanced Production of IL-17A and IL-10 from Peripheral CD4(+) T Cells
por: Kumawat, Ashok Kumar, et al.
Publicado: (2014)

Reduced IL-37 Production Increases Spontaneous Chemokine Expressions in Colon Epithelial Cells
por: Günaltay, Sezin, et al.
Publicado: (2017)

Subphenotypes of inflammatory bowel disease are characterized by specific serum protein profiles
por: Andersson, Erik, et al.
Publicado: (2017)

Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register
por: Thunberg, Joel, et al.
Publicado: (2022)

A combination of the activation marker CD86 and the immune checkpoint marker B and T lymphocyte attenuator (BTLA) indicates a putative permissive activation state of B cell subtypes in healthy blood donors independent of age and sex
por: Axelsson, Susanne, et al.
Publicado: (2020)

Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD
por: Buderus, Stephan, et al.
Publicado: (2015)

Mucosal Gene Transcript Signatures in Treatment Naïve Inflammatory Bowel Disease: A Comparative Analysis of Disease to Symptomatic and Healthy Controls in the European IBD-Character Cohort
por: Vatn, Simen Svendsen, et al.
Publicado: (2022)

Implications of the Westernized Diet in the Onset and Progression of IBD
por: Rizzello, Fernando, et al.
Publicado: (2019)

Fecal Microbiota Transplantation to Patients with Refractory Very Early Onset Ulcerative Colitis
por: Yodoshi, Toshifumi, et al.
Publicado: (2018)

Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents as Second-Line Biologics in Crohn's Disease
por: Eriksson, Carl, et al.
Publicado: (2023)

Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative Colitis
por: Moraes Holst, Luiza, et al.
Publicado: (2022)

Comparison of the prevalence of bacteriocin encoding genes in Lactobacillus spp. isolated from fecal samples of healthy volunteers, IBD-patient and IBD-recovered
por: Miri, Seyedeh Tina, et al.
Publicado: (2022)

Fecal Calprotectin, CRP and Leucocytes in IBD Patients: Comparison of Biomarkers With Biopsy Results
por: Kyle, Barry D, et al.
Publicado: (2020)

Can 2 Different Fecal Calprotectin Assays be Used Interchangeably in IBD Treatment?
por: van Wassenaer, Elsa A., et al.
Publicado: (2022)

Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer
por: Lavelle, Aonghus, et al.
Publicado: (2022)

A48 LYOPHILIZED FECAL MICROBIOTA TRANSPLANT (FMT) DELAYS THE ONSET OF SPONTANEOUS COLITIS IN MUC2-/- MICE
por: Chan, J J, et al.
Publicado: (2023)

Fecal Dipeptidyl Peptidase-4: An Emergent Biomarker in Inflammatory Bowel Disease
por: Pinto-Lopes, Pedro, et al.
Publicado: (2021)

Impact of Diagnostic Delay on Disease Course in Pediatric- versus Adult-Onset Patients with Ulcerative Colitis: Data from the Swiss IBD Cohort
por: Schoepfer, Alain M., et al.
Publicado: (2021)

Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis
por: Barbosa, Jéssica A., et al.
Publicado: (2021)

Effect of fecal microbiota transplantation on experimental colitis in mice
por: Zhou, Julan, et al.
Publicado: (2019)

Patient knowledge of fecal calprotectin in inflammatory bowel disease (IBD): An observational study in Mexico
por: Maldonado-Arriaga, Brenda, et al.
Publicado: (2021)

Phylogenetic analysis of Prevotella copri from fecal and mucosal microbiota of IBS and IBD patients
por: Lo Presti, Alessandra, et al.
Publicado: (2023)

Collagenous Colitis Possibly Associated with Dipeptidyl Peptidase-4 Inhibitor
por: Takedomi, Hironobu, et al.
Publicado: (2022)

P03-024 – Early onset IBD treated by tocilizumab
por: Helbling, R, et al.
Publicado: (2013)

Beyond IBD: the genetics of other early-onset diarrhoeal disorders
por: Stallard, Lorraine, et al.
Publicado: (2023)

MicroRNA Biomarkers in IBD—Differential Diagnosis and Prediction of Colitis-Associated Cancer
por: James, Jaslin P., et al.
Publicado: (2020)

Two‐year effectiveness and safety of golimumab in ulcerative colitis: An IG‐IBD study
por: Pugliese, Daniela, et al.
Publicado: (2021)

Fecal microbiota in pouchitis and ulcerative colitis
por: Li, Kai-Yu, et al.
Publicado: (2016)

Fecal leukocyte in the diagnosis of ulcerative colitis
por: Saraya, Takeshi, et al.
Publicado: (2013)

Faecalibacterium prausnitzii increases following fecal microbiota transplantation in recurrent Clostridioides difficile infection
por: Björkqvist, Olle, et al.
Publicado: (2021)

Simultaneous Assessment of Urinary and Fecal Volatile Organic Compound Analysis in De Novo Pediatric IBD
por: el Manouni el Hassani, Sofia, et al.
Publicado: (2019)

Factors Associated With Fecal Calprotectin Sample Collection Compliance: An IBD Center Quality Improvement Project
por: Fenton, David, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lepmf7a0eed5g2225e42c39jbh